ID   PKN2_RAT                Reviewed;         985 AA.
AC   O08874;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 2.
DT   24-JUL-2024, entry version 182.
DE   RecName: Full=Serine/threonine-protein kinase N2;
DE            EC=2.7.11.13;
DE   AltName: Full=Cardiolipin-activated protein kinase Pak2;
DE   AltName: Full=PKN gamma;
DE   AltName: Full=Protease-activated kinase 2;
DE            Short=PAK-2;
DE   AltName: Full=Protein kinase C-like 2;
DE   AltName: Full=Protein-kinase C-related kinase 2;
DE   AltName: Full=p140 kinase;
GN   Name=Pkn2; Synonyms=Pak2, Prk2, Prkcl2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 138-979, PARTIAL PROTEIN SEQUENCE, ACTIVITY
RP   REGULATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Liver, and Myeloma;
RX   PubMed=9092545; DOI=10.1074/jbc.272.15.10030;
RA   Yu W., Liu J., Morrice N.A., Wettenhall R.E.H.;
RT   "Isolation and characterization of a structural homologue of human PRK2
RT   from rat liver: distinguishing substrate and lipid activator
RT   specificities.";
RL   J. Biol. Chem. 272:10030-10034(1997).
RN   [3]
RP   PROTEIN SEQUENCE OF 34-44 AND 255-266, AUTOPHOSPHORYLATION,
RP   PHOSPHORYLATION, AND TISSUE SPECIFICITY.
RX   PubMed=9121475; DOI=10.1128/mcb.17.4.2247;
RA   Vincent S., Settleman J.;
RT   "The PRK2 kinase is a potential effector target of both Rho and Rac GTPases
RT   and regulates actin cytoskeletal organization.";
RL   Mol. Cell. Biol. 17:2247-2256(1997).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-584 AND THR-959, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: PKC-related serine/threonine-protein kinase and Rho/Rac
CC       effector protein that participates in specific signal transduction
CC       responses in the cell. Plays a role in the regulation of cell cycle
CC       progression, actin cytoskeleton assembly, cell migration, cell
CC       adhesion, tumor cell invasion and transcription activation signaling
CC       processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and
CC       hence decreases CTTN ability to associate with filamentous actin.
CC       Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct
CC       RhoA target required for the regulation of the maturation of primordial
CC       junctions into apical junction formation in bronchial epithelial cells.
CC       Required for G2/M phases of the cell cycle progression and abscission
CC       during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase
CC       activity that is required for establishment of skin cell-cell adhesion
CC       during keratinocytes differentiation. Regulates epithelial bladder
CC       cells speed and direction of movement during cell migration and tumor
CC       cell invasion. Inhibits Akt pro-survival-induced kinase activity.
CC       Mediates Rho protein-induced transcriptional activation via the c-fos
CC       serum response factor (SRF). Involved in the negative regulation of
CC       ciliogenesis. {ECO:0000250|UniProtKB:Q16513}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.13;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.13;
CC   -!- ACTIVITY REGULATION: Kinase activity is activated upon binding to GTP-
CC       bound Rho1/Rac1 GTPases. Activated by caspase-3 (CASP3) cleavage during
CC       apoptosis. Activated by lipids, particularly cardiolipin and to a
CC       lesser extent by other acidic phospholipids and unsaturated fatty
CC       acids. Two specific sites, Thr-817 (activation loop of the kinase
CC       domain) and Thr-959 (turn motif), need to be phosphorylated for its
CC       full activation (By similarity). {ECO:0000250|UniProtKB:Q16513}.
CC   -!- SUBUNIT: Interacts (via the REM repeats) with RHOA (GTP-bound form
CC       preferentially) and interacts (via the REM repeats) with RAC1 (GTP-
CC       bound form preferentially); the interactions induce its
CC       autophosphorylation (By similarity). Interacts with RHOC (By
CC       similarity). Interacts with NCK1 (via SH3 domains) and NCK2 (By
CC       similarity). Interacts with CD44 (By similarity). Interacts (via C-
CC       terminal kinase domain) with PDPK1; the interaction stimulates PDPK1
CC       kinase activity (By similarity). Interacts with MAP3K2; the interaction
CC       activates PRK2 kinase activity in a MAP3K2-independent kinase activity
CC       (By similarity). Interacts (via C-terminal domain) with AKT1; the
CC       interaction occurs with the C-terminal cleavage product of PRK2 in
CC       apoptotic cells (By similarity). Interacts (via C-terminus) with PTPN13
CC       (via PDZ 3 domain) (By similarity). Interacts with CDK10 (By
CC       similarity). {ECO:0000250|UniProtKB:Q16513}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q16513}. Nucleus
CC       {ECO:0000250|UniProtKB:Q16513}. Membrane
CC       {ECO:0000250|UniProtKB:Q8BWW9}. Cell projection, lamellipodium
CC       {ECO:0000250|UniProtKB:Q16513}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q16513}. Cleavage furrow
CC       {ECO:0000250|UniProtKB:Q16513}. Midbody {ECO:0000250|UniProtKB:Q16513}.
CC       Cell junction {ECO:0000250|UniProtKB:Q16513}. Note=Colocalizes with
CC       PTPN13 in lamellipodia-like structures, regions of large actin
CC       turnover. Accumulates during telophase at the cleavage furrow and
CC       concentrates finally around the midbody in cytokinesis. Recruited to
CC       nascent cell-cell contacts at the apical surface of cells.
CC       {ECO:0000250|UniProtKB:Q16513}.
CC   -!- TISSUE SPECIFICITY: Expressed in liver (at protein level).
CC       {ECO:0000269|PubMed:9092545, ECO:0000269|PubMed:9121475}.
CC   -!- DOMAIN: The N-terminal regioninterferes with the interaction between
CC       AKT1 and the C-terminal regionof PKN2. {ECO:0000250}.
CC   -!- DOMAIN: The C1 domain does not bind the diacylglycerol (DAG).
CC   -!- DOMAIN: The apoptotic C-terminal cleavage product inhibits EGF-induced
CC       kinase activity of AKT1 phosphorylation at 'Thr-308' and 'Ser-473'
CC       sites, PDPK1 autophosphorylation and kinases PRKCD and PRKCZ
CC       phosphorylations. {ECO:0000250}.
CC   -!- PTM: Phosphorylated during mitosis (By similarity). Autophosphorylated.
CC       Phosphorylated. Binding to Rho and Rac promotes autophosphorylation and
CC       phosphorylation on serine and threonine residues. Phosphorylated by
CC       CDK10 (By similarity). {ECO:0000250|UniProtKB:Q16513,
CC       ECO:0000269|PubMed:9121475}.
CC   -!- PTM: Proteolytically cleaved by caspase-3 during the induction of
CC       apoptotic cell death (By similarity). Activated by limited proteolysis
CC       with trypsin. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR03012350; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03012657; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; U75358; AAB53364.1; -; mRNA.
DR   AlphaFoldDB; O08874; -.
DR   SMR; O08874; -.
DR   IntAct; O08874; 2.
DR   MINT; O08874; -.
DR   STRING; 10116.ENSRNOP00000034133; -.
DR   iPTMnet; O08874; -.
DR   PhosphoSitePlus; O08874; -.
DR   jPOST; O08874; -.
DR   PaxDb; 10116-ENSRNOP00000034133; -.
DR   UCSC; RGD:620146; rat.
DR   AGR; RGD:620146; -.
DR   RGD; 620146; Pkn2.
DR   eggNOG; KOG0694; Eukaryota.
DR   InParanoid; O08874; -.
DR   PhylomeDB; O08874; -.
DR   Reactome; R-RNO-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-RNO-8980692; RHOA GTPase cycle.
DR   Reactome; R-RNO-9013026; RHOB GTPase cycle.
DR   Reactome; R-RNO-9013149; RAC1 GTPase cycle.
DR   PRO; PR:O08874; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0043296; C:apical junction complex; ISS:UniProtKB.
DR   GO; GO:0032154; C:cleavage furrow; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0030496; C:midbody; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004697; F:diacylglycerol-dependent serine/threonine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0042826; F:histone deacetylase binding; ISS:UniProtKB.
DR   GO; GO:0016301; F:kinase activity; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:RGD.
DR   GO; GO:0070063; F:RNA polymerase binding; ISO:RGD.
DR   GO; GO:0031267; F:small GTPase binding; IEA:InterPro.
DR   GO; GO:0043297; P:apical junction assembly; ISS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0030030; P:cell projection organization; IEA:UniProtKB-KW.
DR   GO; GO:0010631; P:epithelial cell migration; ISS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0032467; P:positive regulation of cytokinesis; ISS:UniProtKB.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0045070; P:positive regulation of viral genome replication; ISO:RGD.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:2000145; P:regulation of cell motility; ISS:UniProtKB.
DR   CDD; cd08687; C2_PKN-like; 1.
DR   CDD; cd11631; HR1_PKN2_2; 1.
DR   CDD; cd11622; HR1_PKN_1; 1.
DR   CDD; cd05589; STKc_PKN; 1.
DR   Gene3D; 1.10.287.160; HR1 repeat; 3.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR037784; C2_PKN.
DR   InterPro; IPR011072; HR1_rho-bd.
DR   InterPro; IPR036274; HR1_rpt_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR037313; PKN_HR1_1.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR050236; Ser_Thr_kinase_AGC.
DR   PANTHER; PTHR24356; SERINE/THREONINE-PROTEIN KINASE; 1.
DR   PANTHER; PTHR24356:SF322; SERINE_THREONINE-PROTEIN KINASE N2; 1.
DR   Pfam; PF02185; HR1; 3.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00742; Hr1; 3.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 1.
DR   SUPFAM; SSF46585; HR1 repeat; 3.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS51860; REM_1; 3.
PE   1: Evidence at protein level;
KW   Acetylation; Apoptosis; ATP-binding; Cell adhesion; Cell cycle;
KW   Cell division; Cell junction; Cell projection;
KW   Cilium biogenesis/degradation; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Kinase; Membrane; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transcription; Transcription regulation;
KW   Transferase.
FT   CHAIN           1..985
FT                   /note="Serine/threonine-protein kinase N2"
FT                   /id="PRO_0000055724"
FT   DOMAIN          33..109
FT                   /note="REM-1 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01207"
FT   DOMAIN          121..204
FT                   /note="REM-1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01207"
FT   DOMAIN          207..286
FT                   /note="REM-1 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01207"
FT   DOMAIN          354..474
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          658..917
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          918..985
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   REGION          111..136
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          352..383
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          383..464
FT                   /note="Necessary to rescue apical junction formation"
FT                   /evidence="ECO:0000250"
FT   REGION          570..590
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          918..978
FT                   /note="Necessary for the catalytic activity"
FT                   /evidence="ECO:0000250"
FT   REGION          979..985
FT                   /note="Negatively regulates the responsiveness of the
FT                   catalytic activity by cardiolipin and is required for
FT                   optimal activation by the GTP-bound RhoA"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        120..136
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        356..383
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        783
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         664..672
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         687
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   SITE            117..118
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000250"
FT   SITE            701..702
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         77
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BWW9"
FT   MOD_RES         110
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16513"
FT   MOD_RES         121
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16513"
FT   MOD_RES         124
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16513"
FT   MOD_RES         303
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16513"
FT   MOD_RES         307
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16513"
FT   MOD_RES         361
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16513"
FT   MOD_RES         363
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16513"
FT   MOD_RES         536
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16513"
FT   MOD_RES         584
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         621
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BWW9"
FT   MOD_RES         632
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16513"
FT   MOD_RES         817
FT                   /note="Phosphothreonine; by PDPK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q16513"
FT   MOD_RES         953
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16513"
FT   MOD_RES         959
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   985 AA;  112069 MW;  AE71D30379715C3D CRC64;
     MASNPDRGEI LLTELQVDSR PLPFSENVSA VQKLDFSDTI VQQKLDDVKD RIKREIRKEL
     KIKEGAENLR KVTTDKKNLA YVDNILKKSN KKLEELHHKL QELNAHIVVS DPEDYTDCPR
     TPDTPNSDSR SSTSNNRRLM ALQKQLDIEL KVKQGAENMI QMYSNGPSKD RKLHGTAQQL
     LQDNKTKIEV IRMHILQAVL TNELAFDNAK PVISPLELRN GRIIEHHFRI EFAVAEGAKN
     VMKLLGSGKV TDRKALSEAQ ARFNESSQKL DLLKYSLEQR LNELPKNHPK SSVVIEELSL
     VASPTLSPRQ SMLSTQNQYS TLSKPAALTG TLEVRLWGAK ISWENVPGRS KATSVALPGW
     SPSENRSSFM SRTSKSKSGS SRNLLKTDDL SNDVCAVLKL DNTVVGQTIW KPISNQSWDQ
     KFTLELDRSR ELEISVYWRD WRSLCAVKFL RLEDFLDNQR HGMALYLEPQ GTLFAEVTFF
     NPVIERRPKL QRQKKIFSKQ QGKTFLRAPQ MNINIATWGR LVRRAIPTVN HSGTFSPQTP
     VPATVPVVDA RTPELAPPAS DSTVTKLDFD LEPEAPPAPP RASSLGEIDD SSELRVLDIP
     GQGSETVFDI ENDRNNMRPK SKSEYELNIP DSSRSCWSVG ELEDKRSQQR FQFNLQDFRC
     CAVLGRGHFG KVLLAEYKHT NEMFAIKALK KGDIVARDEV DSLMCEKRIF ETVNSVRHPF
     LVNLFACFQT KEHVCFVMEY AAGGDLMMHI HTDVFSEPRA VFYAACVVLG LQYLHEHKIV
     YRDLKLDNLL LDTEASVKIA DFGLCKEGMG YGDRTSTFCG TPEFLAPEVL TETSYTRAVD
     WWGLGVLIYE MLVGESPFPG DDEEEVFDSI VNDEVRYPRF LSTEAISIMR RLLRRNPERR
     LGAGEKDAED VKKHPFFRLT DWSALLDKKV KPPFVPTIRG REDVSNFDDE FTSEAPILTP
     PREPRILLEE EQEMFRDFDY VADWC
//
